Kymos Group

📢JOB OFFER We are #hiring a Scientist for our Elemental Analysis Department. The candidate will be assigned the following responsibilities: - Manage, execute, and review tests using ICP-MS and AAS for development studies, method validation and transfers, and routine sample analysis. - Design, supervise, review, and perform method validations by ICP-MS and AAS. - Draft and review related documentation, including SOPs, protocols, guides, and reports. - Manage and write incidents, deviations, OOS, and CAPAs. Requirements: - Degree in Chemistry or Pharmacy. - Experience in Quality Control within the pharmaceutical industry or a CRO. - Proficiency in managing, designing, and performing physicochemical tests on active ingredients, pharmaceuticals, cosmetics, and more. - Experience working under GMP and GLP standards. - Familiarity with pharmacopeias, guidelines, and regulations relevant to GMPs. - Knowledge of the ICH Q3D guideline is highly valued. - Advanced proficiency in English. Join our team today by applying at this link below! 👇 https://lnkd.in/eyZVgcZz

▶ Today, we had the pleasure of welcoming Merck Life Science to our headquarters in Barcelona. We have enjoyed a long-standing relationship with them, as they have been supplying our labs with reagents and equipment for many years. During this visit, they introduced our lab and technical teams to their latest Supelco® range of analytical products which we are excited to test. A huge thanks to Merck for this successful and ongoing partnership!

Join the Kymos Group Team as a QA Analyst! We're looking for a QA Analyst to support our growing team in Cerdanyola del Vallés. Key Responsibilities: - Review manufacturing and packaging batch records and other QA documents. - Support QA Release Scientists with quality agreements and batch certifications. - Review key documentation: CoAs, SOPs, product specs, environmental controls, etc. - Assist with deviations, OOS/OOT, complaints, CAPA, and Change Controls, ensuring GMP compliance. - Contribute to the improvement of our quality system. Requirements: - Superior Technical studies, experience in QA and manufacturing experience is a plus. - Knowledge of Pharmaceutical Analysis, Quality Control, and GMPs. If you're looking for a collaborative, growth-driven environment, apply now! https://lnkd.in/de48KnQJ

🆕💻 New Webinar: 𝐁𝐢𝐨𝐥𝐨𝐠𝐢𝐜𝐚𝐥 𝐈𝐦𝐩𝐮𝐫𝐢𝐭𝐢𝐞𝐬: 𝐒𝐜𝐢𝐞𝐧𝐭𝐢𝐟𝐢𝐜 𝐚𝐧𝐝 𝐑𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐲 𝐀𝐬𝐩𝐞𝐜𝐭𝐬 Join us next Thursday, October 24th, for a joint webinar organized by CPA Italy featuring experts from ASPHALION and Kymos Group. Our colleagues from #Asphalion will discuss the regulatory aspects of #BiologicalImpurities, while our Innovation Director, Carles Celma Lezcano, will share scientific and analytical insights based on our extensive experience with these impurities. 📌 Agenda: - Introduction to biological drugs: definition and particulars - ICH, EMA, and FDA guidelines - General concepts - Requirements for specific types of products - Quality attributes and analytical methods - Case studies - Take home messages - Questions and answers 🔗 For more information and registration, visit: https://lnkd.in/d4g3p2nm

🆕📝 The 2024 #NobelPrize in Medicine brings long-awaited recognition to a once-overlooked molecule: #microRNA, or #miRNA. At Kymos Group, our Germany site (formerly Prolytic) has been a pioneer in this field, developing and validating GLP-compliant methods for quantifying miRNA since 2016. In our latest article, we explore what miRNA is, its functions and therapeutic possibilities, and how we conduct its bioanalysis in our laboratories. ▶ Discover the potential of these molecules for early diagnosis and targeted treatments, and learn about Kymos Group's expertise in miRNA analysis: https://lnkd.in/dfXqi-M5

📆24 ottobre 2024 Biological Impurities: scientific and regulatory aspects https://lnkd.in/dccsaRfP For a more in-depth understanding, there’s an upcoming CPA Italy webinar training live, hosted by experts from Kymos Group and ASPHALION.  This webinar will cover topics such as the definition of biological drugs, regulatory guidelines, quality attributes, and case studies --------------- Biological impurities in pharmaceuticals are a critical concern, both scientifically and from a regulatory perspective. These impurities can arise from various sources, including the raw materials, manufacturing processes, and even the environment. Here are some key points to consider: 🔎Scientific Aspects ⚗️Sources of Biological Impurities ➡️Microbial Contaminants ➡️Endotoxins ➡️Host Cell Proteins (HCPs) ⚗️Detection and Quantification ➡️Analytical Methods ➡️Quality Control 🔎Regulatory Aspects ⚗️Guidelines and Standards ➡️ICH Guidelines ➡️EMA and FDA Regulations ⚗️Compliance and Documentation ➡️Regulatory Submissions ➡️Good Manufacturing Practices (GMP) #gmp #quality #compliance #regulatory #cpaitaly

🆕📝 Today we are launching a new page dedicated to Kymos Group #TransdermalTesting service on our website! #TransdermalPatches are formulated to deliver active substances through the skin directly into the bloodstream at a steady, sustained rate.  Due to their unique attributes, they present different challenges when controlling their quality, efficacy, and safety. Our new page contains all the information and specifics about our cutting-edge technologies and techniques for testing this dosage form. ▶ Visit it to learn more: https://bit.ly/4eJ1xVs or contact us via email at commercial@kymos.com if you need more assistance.

▶ CPHI 2024 has officially ended! It has been a pleasure to meet fantastic professionals and discuss innovative projects with our trusted partners, and we've had plenty of visits and meetings on this year's edition in Milan. We also want to express our sincere gratitude to everyone involved in making the event possible: CPHI Fiera Milano SpA Informa Markets. This has been a resounding success for both our team and the event organizers. As always, CPHI proved to be an invaluable experience. 👋🏻 See you in Frankfurt next year!

🎥 This is how we are doing at our booth #14B69! If you'd like to schedule a meeting, we still have time slots available. Our team looks forward to connecting with you, discussing your projects, and exploring potential collaborations. ▶ We welcome you to visit us!

📢 CPHI Day 2: Let’s get started! Hello from Fiera Milano! We are ready to welcome you to booth #14B69 for a day packed with meetings and new opportunities with our clients and partners. Don’t miss the chance to connect and discover more about our services. Drop by our booth and let's chat about how Kymos Group can support you!